Related references
Note: Only part of the references are listed.Toll-like receptor 3 pre-conditioning increases the therapeutic efficacy of umbilical cord mesenchymal stromal cells in a dextran sulfate sodium-induced colitis model
Patricia Fuenzalida et al.
CYTOTHERAPY (2016)
Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cells Induces a Switch from Classical to Atypical Symptoms in Experimental Autoimmune Encephalomyelitis
Monica Kurte et al.
STEM CELLS INTERNATIONAL (2015)
Th17 cells in inflammation and autoimmunity
Ram Pyare Singh et al.
AUTOIMMUNITY REVIEWS (2014)
Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE)
Forouzan Yousefi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses
Qian-Qian Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Mesenchymal stem cells generate a CD4+CD25+ Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells
Patricia Luz-Crawford et al.
STEM CELL RESEARCH & THERAPY (2013)
Immunomodulatory Properties of Mesenchymal Stem Cells and Their Therapeutic Applications
TacGhee Yi et al.
ARCHIVES OF PHARMACAL RESEARCH (2012)
Mesenchymal Stem Cell treatment for autoinnmune diseases: a critical review
Fernando E. Figueroa et al.
BIOLOGICAL RESEARCH (2012)
Mesenchymal Stem Cells Repress Th17 Molecular Program through the PD-1 Pathway
Patricia Luz-Crawford et al.
PLOS ONE (2012)
Mesenchymal Stem Cell 1 (MSC1)-Based Therapy Attenuates Tumor Growth Whereas MSC2-Treatment Promotes Tumor Growth and Metastasis
Ruth S. Waterman et al.
PLOS ONE (2012)
Anti-Inflammatory Mesenchymal Stem Cells (MSC2) Attenuate Symptoms of Painful Diabetic Peripheral Neuropathy
Ruth S. Waterman et al.
STEM CELLS TRANSLATIONAL MEDICINE (2012)
Immunomodulatory properties and therapeutic application of mesenchymal stem cells
M. Shi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Interpretation of Cellular Proliferation Data: Avoid the Panglossian
Mario Roederer
CYTOMETRY PART A (2011)
Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation
Flavio Carrion et al.
IMMUNOLOGY LETTERS (2011)
Mesenchymal stem cell effects on T-cell effector pathways
Michelle M. Duffy et al.
STEM CELL RESEARCH & THERAPY (2011)
Stem cells in the treatment of inflammatory arthritis
Alan Tyndall et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2010)
A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype
Ruth S. Waterman et al.
PLOS ONE (2010)
Adipose-Derived Mesenchymal Stem Cells Alleviate Experimental Colitis by Inhibiting Inflammatory and Autoimmune Responses
Manuel A. Gonzalez et al.
GASTROENTEROLOGY (2009)
Human Bone Marrow-Derived Mesenchymal Stem Cells Induce Th2-Polarized Immune Response and Promote Endogenous Repair in Animal Models of Multiple Sclerosis
Lianhua Bai et al.
GLIA (2009)
Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis
E. Gonzalez-Rey et al.
GUT (2009)
Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune Encephalomyelitis
Moutih Rafei et al.
MOLECULAR THERAPY (2009)
Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases
Farida Djouad et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Toll-Like Receptor Engagement Enhances the Immunosuppressive Properties of Human Bone Marrow-Derived Mesenchymal Stem Cells by Inducing Indoleamine-2,3-dioxygenase-1 via Interferon-beta and Protein Kinase R
Christiane A. Opitz et al.
STEM CELLS (2009)
Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide
Guangwen Ren et al.
CELL STEM CELL (2008)
Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing notch signaling
Francesco Liotta et al.
STEM CELLS (2008)
Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses
Suzanne L. Tomchuck et al.
STEM CELLS (2008)
Mesenchymal stem cells in health and disease
Antonio Uccelli et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Interferon-γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells
J. M. Ryan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis
Andrea Augello et al.
ARTHRITIS AND RHEUMATISM (2007)
Toll-like receptors and their ligands control mesenchymal stem cell functions
Meirav Pevsner-Fischer et al.
BLOOD (2007)
Cell therapy for autoimmune diseases
Francesco Dazzi et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Immunoregulatory function of mesenchymal stem cells
Antonio Uccelli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells
Mauro Krampera et al.
STEM CELLS (2006)
Human mesenchymal stem cells modulate allogeneic immune cell responses
S Aggarwal et al.
BLOOD (2005)
Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization
LD Meirelles et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Share Paper
